Steven J. Romano

Insider Reports History

Location
New York, NY
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven J. Romano:

Company Role Class Num Shares Value Price $ Report Date Ownership
Silence Therapeutics plc EVP and Chief R&D Officer Employee Share Option (Right to Buy) 300,000 02 Jan 2026 Direct
Dianthus Therapeutics, Inc. /DE/ Director Stock Option (Right to Buy) 12,500 22 May 2025 Direct
Mallinckrodt plc EVP & Chief Sci. Ofcr Ordinary Shares 0 $37.50 16 Jun 2022 Direct
Mallinckrodt plc EVP & Chief Sci. Ofcr Employee Share Options (Right to Buy) 0 16 Jun 2022 Direct

Insider Reports Filed by Steven J. Romano

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLN Silence Therapeutics plc 02 Jan 2026 1 $0 4 EVP and Chief R&D Officer 06 Jan 2026, 16:15
DNTH Dianthus Therapeutics, Inc. /DE/ 22 May 2025 1 $0 4 Director 22 May 2025, 16:42
SLN Silence Therapeutics plc 02 Jan 2025 1 $0 4 EVP and Chief R&D Officer 06 Jan 2025, 16:15
SLN Silence Therapeutics plc 02 Jan 2025 0 $0 3 EVP and Chief R&D Officer 02 Jan 2025, 16:26
DNTH Dianthus Therapeutics, Inc. /DE/ 16 Sep 2024 1 $0 4 Director 18 Sep 2024, 17:38
DNTH Dianthus Therapeutics, Inc. /DE/ 16 Sep 2024 0 $0 3 Director 18 Sep 2024, 17:32
/report/000089924322023426-romano-steven-j-2022-06-16 Mallinckrodt plc 16 Jun 2022 7 $0 4 EVP & Chief Sci. Ofcr 21 Jun 2022, 18:10